Literature DB >> 3621595

Evidence for an increased glycation of IgG in diabetic patients.

P M Danze, A Tarjoman, J Rousseaux, P Fossati, M Dautrevaux.   

Abstract

The levels of non-enzymatically glycated total plasma proteins, albumin and IgG were determined in diabetic and non-diabetic patients using affinity chromatography on boronate-agarose gels. A significant increase in both glycated albumin and IgG, and in total glycated plasma proteins was demonstrated. A good correlation between glycated albumin and glycated hemoglobin was observed, while the correlation between glycated IgG and glycated albumin (or hemoglobin) was lower. This was found probably related to wide variations of glycated IgG for diabetics patients who have high glycated hemoglobin levels. These variations were inversely correlated with total serum IgG. Determination of fructosamine or 5-hydroxymethylfurfural content of IgG showed a significant increase in diabetics. Glycated IgG was found to contain approximately one mole of glucose. The main site of glycation was determined to be present in the Fab (more precisely the Fd) part of the IgG molecule.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3621595     DOI: 10.1016/0009-8981(87)90416-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  14 in total

1.  Enrichment and analysis of nonenzymatically glycated peptides: boronate affinity chromatography coupled with electron-transfer dissociation mass spectrometry.

Authors:  Qibin Zhang; Ning Tang; Jonathan W C Brock; Heather M Mottaz; Jennifer M Ames; John W Baynes; Richard D Smith; Thomas O Metz
Journal:  J Proteome Res       Date:  2007-05-09       Impact factor: 4.466

2.  Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects.

Authors:  Qibin Zhang; Matthew E Monroe; Athena A Schepmoes; Therese R W Clauss; Marina A Gritsenko; Da Meng; Vladislav A Petyuk; Richard D Smith; Thomas O Metz
Journal:  J Proteome Res       Date:  2011-06-10       Impact factor: 4.466

3.  Monitoring nonenzymatic glycation of human immunoglobulin G by methylglyoxal and glyoxal: A spectroscopic study.

Authors:  Praveen K Pampati; Sreekanth Suravajjala; Joel A Dain
Journal:  Anal Biochem       Date:  2010-09-17       Impact factor: 3.365

4.  Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus.

Authors:  S Suzuki; M Koga; S Amamiya; A Nakao; K Wada; K Okuhara; S Hayano; A R Sarhat; H Takahashi; K Matsuo; Y Tanahashi; K Fujieda
Journal:  Diabetologia       Date:  2011-06-05       Impact factor: 10.122

5.  Detection of glycated gastric inhibitory polypeptide within the intestines of diabetic obese (ob/ob) mice.

Authors:  M H Mooney; Y H Abdel-Wahab; L M Morgan; F P O'Harte; P R Flatt
Journal:  Endocrine       Date:  2001-12       Impact factor: 3.633

6.  A study of the antidiabetic activity of Barleria prionitisLinn.

Authors:  Reema Dheer; Pradeep Bhatnagar
Journal:  Indian J Pharmacol       Date:  2010-04       Impact factor: 1.200

7.  Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients.

Authors:  P Nivoit; N Wiernsperger; P Moulin; M Lagarde; C Renaudin
Journal:  Diabetologia       Date:  2003-10-24       Impact factor: 10.122

8.  Glycation increases the vascular clearance rate of IgG in mice.

Authors:  D M Kennedy; A W Skillen; C H Self
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

9.  Non enzymatic glycosylation of IgG and their urinary excretion in patients with diabetic nephropathy.

Authors:  Kinnari Mistry; Kiran Kalia
Journal:  Indian J Clin Biochem       Date:  2009-07-09

10.  Glycation of monoclonal antibodies impairs their ability to bind antigen.

Authors:  D M Kennedy; A W Skillen; C H Self
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.